VISTAGEN THERAPEUTICS, INC. Finance Lease, Liability, Undiscounted Excess Amount
VISTAGEN THERAPEUTICS, INC. (VTGN) had Finance Lease, Liability, Undiscounted Excess Amount of $3.10 thousand as of 2023-03-31, per its 10-K filed 2023-06-28.
Discontinued › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2023-06-28
- 2023-03-31: Finance Lease, Liability, Undiscounted Excess Amount $3.10K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2023-03-31 | $3.10K 10-K · filed 2023-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |